MoonLake Immunotherapeutics
MLTX · NASDAQ
Bulios Fair Price
$7
39.0% downside
Trenutna cena
$11.47
Po podatkih Bulios Fair Price je delnica MLTX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
MoonLake Immunotherapeutics is a biotechnology company focused on developing immunotherapies for the treatment of autoimmune diseases and cancer. The company utilizes advanced technology that combines biological molecules and monoclonal antibodies for targeted therapy, focusing on specific immune pathways that are critical for the development of various diseases. MoonLake specializes in developing drugs for conditions such as psoriasis, cancer, and other autoimmune disorders, aiming to provide new and effective therapeutic options for patients with these serious diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Jorge Santos da Silva
Employees
130
Headquarters
Zug
Prihajajoči dogodki
Earnings
Upcoming earnings report